Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sorrento
Welcome,
Profile
Billing
Logout
31 Products
1 Disease
31 Products
42 Trials
1393 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Cynviloq
(paclitaxel polymeric micelle formulation) / Sorrento, Samyang Group, ImmunityBio
Fujovee
(abivertinib) / Sorrento
socazolimab
(STI-A1014) / Sorrento
ZTlido
(lidocaine patch 1.8%) / Sorrento
IMC-001
/ Sorrento, Immuneoncia Therap
gene-modified anti-CEA T cells
/ Sorrento
resiniferatoxin
(MCP-101) / Sorrento
Oqory
(samtonadstrocel) / Sorrento
trastuzumab botidotin
(A166) / Sichuan Kelun Pharma
Elyxyb
(celecoxib) / Dr. Reddy’s, Collegium Pharma, Sorrento
Ovydso
(olgotrelvir) / Sorrento
STI-6129
/ Sorrento
COVI-AMG
(plutavimab) / Sorrento
ESG401
/ Escugen Biotechnology, Sorrento
CMAB008
(infliximab biosimilar) / Mabpharm Limited, Sorrento, Shandong Kexing Bioproducts
COVI-DROPS
(STI-2099) / Sorrento
Semdexa
(dexamethasone) / Sorrento
Seprehvir
(HSV1716) / Sorrento
AC0058TA
/ Sorrento
Enlituo
(cetuximab biosimilar) / Mabpharm Limited, Sorrento
Ztlido 5.4%
(lidocaine topical patch 5.4%) / Sorrento
naltrexone low dose delayed burst release
(SP-104) / Sorrento
COVI-GUARD
(STI-1499) / Sorrento, Mount Sinai
STI-1492
/ Sorrento
STI-6643
/ Sorrento
STI-9199
/ Sorrento
Seprehvec
(STI1386) / Sorrento
anti-CD38 A2 CAR-T cells
/ Celularity, Sorrento
nab-paclitaxel/rituximab nanoparticle
(AR160) / Sorrento
sumatriptan succinate transdermal
(KC5010) / Sorrento
